NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

Iradimed Corp (NASDAQ:IRMD) announced its quarterly earnings results on Tuesday, October, 30th. The medical equipment provider reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.04. The medical equipment provider had revenue of $7.62 million for the quarter, compared to analyst estimates of $7.43 million. Iradimed had a net margin of 22.51% and a return on equity of 16.24%. View Iradimed's Earnings History.

Iradimed is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Iradimed.

Iradimed will be holding an earnings conference call on Thursday, February 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Media stories about IRMD stock have been trending negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Iradimed earned a media sentiment score of -2.5 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the next few days. View News Stories for Iradimed.

Iradimed saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 460,900 shares, an increase of 7.7% from the December 15th total of 428,000 shares. Based on an average daily volume of 67,700 shares, the days-to-cover ratio is currently 6.8 days. Approximately 8.5% of the shares of the stock are sold short. View Iradimed's Current Options Chain.

Some companies that are related to Iradimed include Cryolife (CRY), Tactile Systems Technology (TCMD), Luminex (LMNX), Axonics Modulation Technologies (AXNX), Orthofix Medical (OFIX), Intersect ENT (XENT), Orthopediatrics (KIDS), LeMaitre Vascular (LMAT), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), SI-Bone (SIBN), AngioDynamics (ANGO), SurModics (SRDX) and OraSure Technologies (OSUR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), Palo Alto Networks (PANW), Gilead Sciences (GILD), Alphabet (GOOG), Paypal (PYPL), Alibaba Group (BABA), Mastercard (MA), Verizon Communications (VZ) and ABIOMED (ABMD).

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRMD stock can currently be purchased for approximately $25.76.

Iradimed has a market capitalization of $295.72 million and generates $30.44 million in revenue each year. The medical equipment provider earns $6.30 million in net income (profit) each year or $0.43 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

The official website for Iradimed is http://www.iradimed.com/.

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]